Actithera

Actithera is discovering and developing novel Radiotherapeutics for the treatment of cancer. Actithera’s technology is based on unique medicinal chemistry approaches promising to deliver Radiotherapeutics with with significant differentiation and larger therapeutic windows . Current pipeline includes differentiated best- and first-in-class small molecule and peptide based programs targeting various solid tumors. Company was incepted by M Ventures and Arkin Bio-Holdings in 2020.